OTC and ornithine carbamoyltransferase deficiency: Ogino and colleagues reported a patient with OTC deficiency presenting on day one of life, who had undetectable liver OTC enzyme activity, and a hemizygous deep intronic variant (c.540 + 265G>A) was identified (Ogino et al., 2007).